Summary:
To evaluate the safety, tolerability, and response profile of NYX-783 in a Post-Traumatic Stress Disorder population.
Inclusion Criteria:
- A primary diagnosis of PTSD (DSM-5 criteria, APA 2013) with the primary traumatic event occurring ≥12 months prior to screening.
- PCL-5 ≥38 at screening.
- CAPS-5 total score ≥30 at screening.
Qualified Participants May Receive:
Monetary compensation and study-related care at no cost to the participant.